+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome



Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome



Human Reproduction 23(6): 1431-1438



BACKGROUND: Women with polycystic ovary syndrome (PCOS) frequently exhibit central obesity, glucose intolerance, atherogenic dyslipidaemia and hypertension which are characteristic features of the metabolic syndrome (MetS).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 030419929

Download citation: RISBibTeXText

PMID: 18359783

DOI: 10.1093/humrep/den090


Related references

Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome. Gynecological Endocrinology 32(5): 390-394, 2015

Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertility and Sterility 90(4): 1139-1143, 2007

Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome. European Journal of Endocrinology 161(3): 411-418, 2009

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism 95(5): 2038-2049, 2010

Apolipoprotein B/apolipoprotein A1 ratio is a good predictive marker of metabolic syndrome and pre-metabolic syndrome in Chinese adolescent women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 39(1): 203-209, 2013

Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Fertility and Sterility 107(4): 1048-1054, 2017

Waist Circumference Coupled with Either HDL-C or TG Can Be Used as a Diagnostic Marker for Metabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome. International Journal of Endocrinology 2018: 6102085-6102085, 2018

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 89(11): 5454-5461, 2004

Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria. Hong Kong Medical Journal 11(5): 336-341, 2005

Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women?. Seminars in Reproductive Medicine 26(1): 35-38, 2008

Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia. Electronic Physician 9(11): 5697-5704, 2018

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Practice & Research. Clinical Obstetrics & Gynaecology 18(5): 803-812, 2004

Advanced oxidation protein products are increased in women with polycystic ovary syndrome: relationship with traditional and nontraditional cardiovascular risk factors in patients with polycystic ovary syndrome. Fertility and Sterility 92(4): 1372-1377, 2008

Metabolic and cardiovascular changes in women with polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 99(2): 87-90, 2007

Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics 32(12): 1749-1756, 2016